Cinolazepam

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Cinolazepam
Cinolazepam.svg
Cinolazepam3d.png
Clinical data
Trade names Gerodorm
AHFS/Drugs.com cinolazepam
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability 90–100%
Metabolism Hepatic
Elimination half-life 9 hours[1]
Excretion Renal
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
Formula C18H13ClFN3O2
Molar mass 357.8
3D model (JSmol)
Chirality Racemic mixture
 ☒N☑Y (what is this?)  (verify)

Cinolazepam[2] (marketed under the brand name Gerodorm)[3] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as a hypnotic.

Cinolazepam is not approved for sale in the United States or Canada.

See also[edit]

References[edit]

  1. ^ Saletu, B.; G. Kindshofer; P. Anderer; J. Grunberger (1987). "Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise". International Journal of Clinical Pharmacology Research. 7 (5): 407–18. PMID 2889679. 
  2. ^ US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
  3. ^ Lannacher Romania (1999). "Gerodorm". Produse Gerot inregistrate in Romania (in Romanian). Archived from the original on 11 October 2006. Retrieved 17 August 2006. 

External links[edit]